Small Business Innovation Research Funding

Key points

  • NIOSH co-sponsors grants for the Small Business Innovation Research (SBIR) program.
  • SBIR helps businesses commercialize innovations from federal research.
  • Interested applicants are encouraged to review the list of NIOSH topics.
Work in office holding a coffee cup looking hopeful

Background

The HHS Small Business Innovation Research (SBIR) program is a partnership among federal agencies. The Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health participate. The goals of the program are to:

  • Stimulate technological innovation
  • Meet federal research and development needs
  • Increase private sector commercialization of innovations developed through federal R&D funding
  • Foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged (SDB) persons and women-owned small businesses (WOSB).

NIOSH participates by funding SBIR grants related to occupational safety and health.

Funding by category

R43/44 - Phase I and II

SBIR is a phased program. The main objective Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the end of Phase II, small businesses are expected to fully commercialize their product or technology using non-SBIR funds. These funds could be either federal or non-federal.

NIOSH Topics for SBIR‎

Interested applicants are encouraged to review the NIOSH topics identified in SBIR/STTR Program Descriptions and Research Topics Document (pgs 180-184)

Administrative supplements to promote diversity

PA-24-255: Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed) (nih.gov)
PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (nih.gov)

Additional funds may be awarded as supplements to parent awards. These funds for recruiting and supporting students, post-doctorates, and eligible investigators promote diversity in the research and entrepreneurial workforce. This includes those from groups that have been shown to be underrepresented in health-related research or in the SBIR program.

Ongoing funding opportunities

The announcements listed below are published in the NIH Guide to Grants and Contracts. Each announcement specifies the type of grant activity supported, and information needed to submit a grant application.

PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (nih.gov)
PAR-24-131: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
PAR-24-132: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
PA-24-255: Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed) (nih.gov)

Previous funding opportunities

These funding announcements have expired and been reissued. The links are included here as a reference.

Print
Content Source:
National Institute for Occupational Safety and Health